vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and Star Holdings (STHO). Click either name above to swap in a different company.

Star Holdings is the larger business by last-quarter revenue ($25.4M vs $19.2M, roughly 1.3× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -75.5%, a 68.7% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -22.6%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -0.2%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Blue Star Ltd is an Indian multinational home appliances company, headquartered in Mumbai. It specializes in air conditioning, commercial refrigeration and MEP. It is the country's second largest homegrown player in the air conditioning space.

APYX vs STHO — Head-to-Head

Bigger by revenue
STHO
STHO
1.3× larger
STHO
$25.4M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+57.3% gap
APYX
34.7%
-22.6%
STHO
Higher net margin
APYX
APYX
68.7% more per $
APYX
-6.8%
-75.5%
STHO
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
-0.2%
STHO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
STHO
STHO
Revenue
$19.2M
$25.4M
Net Profit
$-1.3M
$-19.1M
Gross Margin
62.6%
Operating Margin
0.1%
-91.7%
Net Margin
-6.8%
-75.5%
Revenue YoY
34.7%
-22.6%
Net Profit YoY
71.9%
81.3%
EPS (diluted)
$-1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
STHO
STHO
Q4 25
$19.2M
$25.4M
Q3 25
$12.9M
$28.1M
Q2 25
$11.4M
$42.1M
Q1 25
$9.4M
$14.6M
Q4 24
$14.2M
$32.8M
Q3 24
$11.5M
$24.6M
Q2 24
$12.1M
$30.6M
Q1 24
$10.2M
$25.4M
Net Profit
APYX
APYX
STHO
STHO
Q4 25
$-1.3M
$-19.1M
Q3 25
$-2.0M
$1.8M
Q2 25
$-3.8M
$-39.3M
Q1 25
$-4.2M
$-7.6M
Q4 24
$-4.6M
$-102.6M
Q3 24
$-4.7M
$91.9M
Q2 24
$-6.6M
$-27.1M
Q1 24
$-7.6M
$-49.0M
Gross Margin
APYX
APYX
STHO
STHO
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
STHO
STHO
Q4 25
0.1%
-91.7%
Q3 25
-6.5%
1.0%
Q2 25
-22.6%
-94.5%
Q1 25
-32.4%
-55.0%
Q4 24
-21.4%
-314.1%
Q3 24
-31.6%
Q2 24
-45.7%
-91.5%
Q1 24
-64.6%
-192.6%
Net Margin
APYX
APYX
STHO
STHO
Q4 25
-6.8%
-75.5%
Q3 25
-15.4%
6.4%
Q2 25
-33.2%
-93.5%
Q1 25
-44.0%
-52.0%
Q4 24
-32.5%
-313.1%
Q3 24
-40.9%
374.3%
Q2 24
-54.0%
-88.8%
Q1 24
-74.0%
-192.6%
EPS (diluted)
APYX
APYX
STHO
STHO
Q4 25
$-1.52
Q3 25
$0.14
Q2 25
$-2.95
Q1 25
$-0.57
Q4 24
$-7.69
Q3 24
$6.90
Q2 24
$-0.19
$-2.04
Q1 24
$-0.22
$-3.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
STHO
STHO
Cash + ST InvestmentsLiquidity on hand
$31.7M
$50.1M
Total DebtLower is stronger
$37.5M
$268.7M
Stockholders' EquityBook value
$14.5M
$251.8M
Total Assets
$66.8M
$570.2M
Debt / EquityLower = less leverage
2.58×
1.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
STHO
STHO
Q4 25
$31.7M
$50.1M
Q3 25
$25.1M
$40.6M
Q2 25
$29.3M
$44.2M
Q1 25
$31.0M
$30.3M
Q4 24
$31.7M
$35.0M
Q3 24
$28.0M
$45.0M
Q2 24
$32.7M
$48.3M
Q1 24
$37.3M
$45.7M
Total Debt
APYX
APYX
STHO
STHO
Q4 25
$37.5M
$268.7M
Q3 25
$37.5M
$259.3M
Q2 25
$37.5M
$245.4M
Q1 25
$37.5M
$231.5M
Q4 24
$37.5M
$217.3M
Q3 24
$37.5M
$201.2M
Q2 24
$197.2M
Q1 24
$195.0M
Stockholders' Equity
APYX
APYX
STHO
STHO
Q4 25
$14.5M
$251.8M
Q3 25
$5.8M
$275.4M
Q2 25
$7.3M
$276.1M
Q1 25
$10.5M
$316.1M
Q4 24
$14.2M
$324.3M
Q3 24
$11.0M
$427.5M
Q2 24
$14.7M
$335.3M
Q1 24
$20.3M
$362.4M
Total Assets
APYX
APYX
STHO
STHO
Q4 25
$66.8M
$570.2M
Q3 25
$57.4M
$595.9M
Q2 25
$58.2M
$589.9M
Q1 25
$60.2M
$618.2M
Q4 24
$64.8M
$608.7M
Q3 24
$60.7M
$696.5M
Q2 24
$65.4M
$601.0M
Q1 24
$70.7M
$622.9M
Debt / Equity
APYX
APYX
STHO
STHO
Q4 25
2.58×
1.07×
Q3 25
6.41×
0.94×
Q2 25
5.17×
0.89×
Q1 25
3.57×
0.73×
Q4 24
2.64×
0.67×
Q3 24
3.40×
0.47×
Q2 24
0.59×
Q1 24
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
STHO
STHO
Operating Cash FlowLast quarter
$-2.5M
$-11.7M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
STHO
STHO
Q4 25
$-2.5M
$-11.7M
Q3 25
$-3.5M
$5.3M
Q2 25
$-1.2M
$-2.6M
Q1 25
$-702.0K
$-6.3M
Q4 24
$-2.9M
$-31.3M
Q3 24
$-4.4M
$-3.8M
Q2 24
$-4.3M
$-6.4M
Q1 24
$-6.3M
$-14.2M
Free Cash Flow
APYX
APYX
STHO
STHO
Q4 25
$-2.8M
Q3 25
$-4.1M
Q2 25
$-1.5M
Q1 25
$-757.0K
Q4 24
$-3.2M
Q3 24
$-4.6M
Q2 24
$-4.6M
Q1 24
$-6.4M
FCF Margin
APYX
APYX
STHO
STHO
Q4 25
-14.6%
Q3 25
-31.5%
Q2 25
-13.2%
Q1 25
-8.0%
Q4 24
-22.4%
Q3 24
-40.0%
Q2 24
-38.0%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
STHO
STHO
Q4 25
1.4%
Q3 25
4.0%
Q2 25
2.3%
Q1 25
0.6%
Q4 24
1.7%
Q3 24
1.3%
Q2 24
2.4%
Q1 24
0.3%
Cash Conversion
APYX
APYX
STHO
STHO
Q4 25
Q3 25
2.95×
Q2 25
Q1 25
Q4 24
Q3 24
-0.04×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

STHO
STHO

Land Development$13.0M51%
Other Income Revenue$9.3M37%
Operating Lease Income$2.0M8%
Other$1.2M5%

Related Comparisons